Cargando…
Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration
Background: CD161 has been identified as a prognostic biomarker in many neoplasms, but its role in breast cancer (BC) has not been fully explained. We aimed to investigate the molecular mechanism and prognostic value of CD161 in BC. Methods: CD161 expression profile was extracted from TIMER, Oncomin...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561259/ https://www.ncbi.nlm.nih.gov/pubmed/36246587 http://dx.doi.org/10.3389/fgene.2022.996345 |